Broker Recommendations
15 Oct
Citi cautious on Indivior until evidence of acceleration to product release
Pharmaceuticals business Indivior had its target price lowered from 350p to 240p by investment bank Citi due to concern that there is not “sufficient evidence” that the launch of Sublocade is accelerating.
15 Oct
Peel Hunt lowers estimates on Superdry as weather and FX clouds loom
Analysts at Peel Hunt lowered their forecasts for Superdry after the retailer announced a series of blows to its bottom line on Monday.
15 Oct
RBC Capital cuts Convatec target but insists it still has 'attractive qualities'
RBC Capital Markets downgraded its target price on Convatec to 210p from 240p on Monday after the medical equipment maker warned on profits and announced the departure of its chief executive.